The contextual fear conditioning deficit presented by spontaneously hypertensive rats (SHR) is not improved by mood stabilizers

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 35, Issue 7, 2011, Pages 1607-1611

  Calzavara, Mariana Bendlin ^a   Medrano, Wladimir Agostini ^a   Levin, Raquel ^a   Libânio, Tânia Cristina ^a   de Alencar Ribeiro, Rosana ^a   Abílio, Vanessa Costhek ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Bipolar disorder; Contextual fear conditioning; Lamotrigine; Lithium; Schizophrenia; SHR

Indexed keywords

LAMOTRIGINE; LITHIUM;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; BEHAVIORAL SCIENCE; CATALEPSY; CONDITIONING; CONTEXTUAL FEAR CONDITIONING DEFICIT; CONTROLLED STUDY; DRUG SENSITIVITY; DRUG TREATMENT FAILURE; EMOTIONAL DISORDER; FEAR; FOOTSHOCK; LOCOMOTION; LONG TERM CARE; MALE; NONHUMAN; RAT; REINFORCEMENT; SHORT COURSE THERAPY; SPONTANEOUSLY HYPERTENSIVE RAT; TASK PERFORMANCE;

AFFECT; ANIMALS; ANTIMANIC AGENTS; CONDITIONING (PSYCHOLOGY); FEAR; LITHIUM CARBONATE; LOCOMOTION; MALE; MOOD DISORDERS; RATS; RATS, INBRED SHR; RATS, WISTAR;

EID: 79961129078     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2011.06.005     Document Type: Article

References (49)

1. Addington J., Addington D. Facial affect recognition and information processing in schizophrenia and bipolar disorder. Schizophr Res 1998, 32(3):171-181.
2. Amann B., Grunze H., Vieta E., Trimble M. Antiepileptic drugs and mood stability. Clin EEG Neurosci 2007, 38(2):116-123.
3. Arban R., Maraia G., Brackenborough K., Winyard L., Wilson A., Gerrard P., et al. Evaluation of the effects of lamotrigine, valproate and carbamazepine in a rodent model of mania. Behav Brain Res 2005, 158:123-132.
4. Becker A., Peters B., Schroeder H., Mann T., Huether G., Grecksch G. Ketamine-induced changes in rat behaviour: a possible animal model of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2003, 27:687-700.
5. Berlin H.A. Antiepileptic drugs for the treatment of post-traumatic stress disorder. Curr Psychiatry Rep 2007, 9:291-300.
6. Bowden C.L. Lamotrigine in the treatment of bipolar disorder. Expert Opin Pharmacother 2002, 3(10):1513-1519.
7. Brignell C.M., Curran H.V. Drugs, sweat, and fears: a comparison of the effects of diazepam and methylphenidate on fear conditioning. Psychopharmacology (Berl) 2006, 186(4):504-516.
8. Burghardt N.S., Sullivan G.M., McEwen B.S., Gorman J.M., LeDoux J.E. The selective serotonin reuptake inhibitor citalopram increases fear after acute treatment but reduces fear with chronic treatment: a comparison with tianeptine. Biol Psychiatry 2004, 55:1171-1178.
9. Calabrese J.R., Huffman R.F., White R.L., Edwards S., Thompson T.R., Ascher J.A., et al. Lamotrigine in the acute treatment of bipolar depression: results of five double-blind, placebo-controlled clinical trials. Bipolar Disord 2008, 10(2):323-333.
10. Calzavara M.B., Lopez G.B., Abílio V.C., Silva R.H., Frussa-Filho R. Role of anxiety levels in memory performance of spontaneously hypertensive rats. Behav Pharmacol 2004, 15(8):545-553.
11. Calzavara M.B., Medrano W.A., Levin R., Kameda S.R., Andersen M.L., Tufik S., et al. Neuroleptic drugs revert the contextual fear conditioning deficit presented by spontaneously hypertensive rats: a potential animal model of emotional context processing in schizophrenia?. Schizophr Bull 2009, 35(4):748-759.
12. Calzavara M.B., Levin R., Medrano W.A., Almeida V., Frois-Sampaio A.P., Barone L.C., Frussa-Filho R., Abilio V.C. Effects of antipsychotics and amphetamine on social behaviors of the Spontaneously Hypertensive Rat. Behav Brain Res 2011, 225(1):15-22.
13. Chen H., Kennedy W.K., Dorfman J.H., Fincham J.E., Reeves J., Martin B.C. The effect of adjunctive mood stabilizers on antipsychotic utilization pattern and health resource utilization for Medicaid enrollees with schizophrenia. Curr Med Res Opin 2007, 23(6):1351-1365.
14. Corrêa C., Amboni G., Assis L.C., Martins M.R., Kapczinski F., Streck E.L., et al. Effects of lithium and valproate on hippocampus citrate synthase activity in an animal model of mania. Prog Neuropsychopharmacol Biol Psychiatry 2007, 31:887-891.
15. Daban C., Martínez-Arán A., Torrent C., Sánchez-Moreno J., Goikolea J.M., Benabarre A., et al. Cognitive functioning in bipolar patients receiving lamotrigine: preliminary results. J Clin Psychopharmacol 2006, 26(2):178-181.
16. Eren I., Naziroǧlu M., Demirdaş A. Protective effects of lamotrigine, aripiprazole and escitalopram on depression-induced oxidative stress in rat brain. Neurochem Res 2007, 32(7):1188-1195.
17. Fanselow M.S., Helmstetter F.J. Conditional analgesia, defensive freezing, and benzodiazepines. Behav Neurosci 1988, 102(2):233-243.
18. Foreman M.M., Hanania T., Eller M. Anxiolytic effects of lamotrigine and JZP-4 in the elevated plus maze and in the four plate conflict test. Eur J Pharmacol 2009, 14;602(2-3):316-320.
19. Fountoulakis K.N., Vieta E. Treatment of bipolar disorder: a systematic review of available data and clinical perspectives. Int J Neuropsychopharmacol 2008, 11(7):999-1029.
20. Frey B.N., Valvassori S.S., Réus G.Z., Martins M.R., Petronilho F.C., Bardini K., et al. Effects of lithium and valproate on amphetamine-induced oxidative stress generation in an animal model of mania. J Psychiatry Neurosci 2006, 31(5):326-332.
21. Gao K., Gajwani P., Elhaj O., Calabrese J.R. Typical and atypical antipsychotics in bipolar depression. J Clin Psychiatry 2005, 66(11):1376-1385.
22. Gilron I., Watson C.P., Cahill C.M., Moulin D.E. Neuropathic pain: a practical guide for the clinician. CMAJ 2006, 175:265-275.
23. Haldane M., Jogia J., Cobb A., Kozuch E., Kumari V., Frangou S. Changes in brain activation during working memory and facial recognition tasks in patients with bipolar disorder with lamotrigine monotherapy. Eur Neuropsychopharmacol 2008, 18(1):48-54.
24. Hard E., Carlsson S.G., Jern S., Larsson K., Lindh A.S., Svensson L. Behavioral reactivity in spontaneously hypertensive rats. Physiol Behav 1985, 35(4):487-492.
25. Hernandez C.M., Høifødt H., Terry A.V. Spontaneously hypertensive rats: further evaluation of age-related memory performance and cholinergic marker expression. J Psychiatry Neurosci 2003, 28(3):197-209.
26. Herz M.I., Melville C. Relapse in schizophrenia. Am J Psychiatry 1980, 137:801-805.
27. Inoue T., Hashimoto S., Tsuchiya K., Izumi T., Ohmori T., Koyama T. Effect of citalopram, a selective serotonin reuptake inhibitor, on the acquisition of conditioned freezing. Eur J Pharmacol 1996, 311:1-6.
28. Inoue T., Li X.B., Abekawa T., Kitaichi Y., Izumi T., Nakagawa S. Selective serotonin reuptake inhibitor reduces conditioned fear through its effect in the amygdala. Eur J Pharmacol 2004, 497:311-316.
29. Janowsky D.S., Risch C. Amphetamine psychosis and psychotic symptoms. Psychopharmacology 1979, 65:73-77.
30. Knardahl S., Sagvolden T. Regarding hyperactivity of the SHR in the open-field test. Behav Neural Biol 1981, 32:274-275.
31. Kohler C.G., Martin E.A. Emotional processing in schizophrenia. Cogn Neuropsychiatry 2006, 11(3):250-271.
32. Lamberty Y., Margineanu D.G., Klitgaard H. Effect of the new antiepileptic drug levetiracetam in an animal model of mania. Epilepsy Behav 2001, 2:454-459.
33. LeDoux J.E. Emotion circuits in the brain. Annu Rev Neurosci 2000, 23:155-184.
34. Malhi G.S., Adams D., Berk M. Is lithium in a class of its own? A brief profile of its clinical use. Aust N Z J Psychiatry 2009, 43(12):1096-1104.
35. Marsh P.J., Williams L.M. ADHD and schizophrenia phenomenology: visual scanpaths to emotional faces as a potential psychophysiological marker?. Neurosci Biobehav Rev 2006, 30(5):651-665.
36. Meador K.J., Loring D.W., Vahle V.J., Ray P.G., Werz M.A., Fessler A.J., et al. Cognitive and behavioral effects of lamotrigine and topiramate in healthy volunteers. Neurology 2005, 64(12):2108-2114.
37. Meneses A., Ponce-Lopez T., Tellez R., Gonzalez R., Castillo C., Gasbarri A. Effects of d-amphetamine on short- and long-term memory in spontaneously hypertensive, Wistar-Kyoto and Sprague-Dawley rats. Behav Brain Res 2011, 216(1):472-476.
38. Mula M., Pini S., Cassano G.B. The role of anticonvulsant drugs in anxiety disorders: a critical review of the evidence. J Clin Psychopharmacol 2007, 27(3):263-272.
39. Munro G., Erichsen H.K., Mirza N.R. Pharmacological comparison of anticonvulsant drugs in animal models of persistent pain and anxiety. Neuropharmacology 2007, 53(5):609-618.
40. Muraki I., Inoue T., Hashimoto S., Izumi T., Ito K., Ohmori T., et al. Effect of subchronic lithium carbonate treatment on anxiolytic-like effect of citalopram and MKC-242 in conditioned fear stress in the rat. Eur J Pharmacol 1999, 383(3):223-229.
41. Pezze M.A., Feldon J. Mesolimbic dopaminergic pathways in fear conditioning. Prog Neurobiol 2004, 74(5):301-320.
42. Phillips M.L., Drevets W.C., Rauch S.L., Lane R. Neurobiology of emotion perception II: implications for major psychiatric disorders. Biol Psychiatry 2003, 54(5):515-528.
43. Resstel L.B., Joca S.R., Moreira F.A., Corrêa F.M., Guimarães F.S. Effects of cannabidiol and diazepam on behavioral and cardiovascular responses induced by contextual conditioned fear in rats. Behav Brain Res 2006, 25(172):294-298. (2).
44. Santos J.M., Martinez R.C.R., Brandão M.L. Effects of acute and subchronic treatments with fluoxetine and desipramine on the memory of fear in moderate and high-intensity contextual conditioning. Eur J Pharmacol 2006, 542:121-128.
45. Shannon H.E., Love P.L. Effects of antiepileptic drugs on learning as assessed by a repeated acquisition of response sequences task in rats. Epilepsy Behav 2007, 10(1):16-25.
46. Tiihonen J., Wahlbeck K., Kiviniemi V. The efficacy of lamotrigine in clozapine-resistant chizophrenia: a systematic review and meta-analysis. Schizophr Res 2009, 109(1-3):10-14.
47. Tsaltas E., Kyriazi T., Poulopoulou C., Kontis D., Maillis A. Enhancing effects of lithium on memory are not by-products of learning or attentional deficits. Behav Brain Res 2007, 180(2):241-245.
48. Van den Buuse M., de Jong W. Differential effects of dopaminergic drugs on open-field behavior of spontaneously hypertensive rats and normotensive Wistar-Kyoto rats. J Pharmacol Exp Ther 1989, 248:1189-1196.
49. Van Lieshout R.J., MacQueen G.M. Efficacy and acceptability of mood stabilisers in the treatment of acute bipolar depression: systematic review. Br J Psychiatry 2010, 196:266-273.